198 related articles for article (PubMed ID: 37407116)
1. Dyslipidemia in Human Immunodeficiency Virus Disease: JACC Review Topic of the Week.
Kalra DK; Vorla M; Michos ED; Agarwala A; Virani S; Duell PB; Raal FJ
J Am Coll Cardiol; 2023 Jul; 82(2):171-181. PubMed ID: 37407116
[TBL] [Abstract][Full Text] [Related]
2. Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection.
Gebhardt A; Fichtenbaum CJ
Expert Opin Pharmacother; 2019 Oct; 20(14):1719-1729. PubMed ID: 31232617
[No Abstract] [Full Text] [Related]
3. The Evolving Landscape of ASCVD Risk Among Patients With HIV.
Malvestutto C
J Fam Pract; 2022 Jul; 71(6 Suppl):S58-S62. PubMed ID: 35960946
[TBL] [Abstract][Full Text] [Related]
4. Effects of statins beyond lipid-lowering agents in ART-treated HIV infection.
Mehraj V; Chen J; Routy JP
Front Immunol; 2024; 15():1339338. PubMed ID: 38655259
[TBL] [Abstract][Full Text] [Related]
5. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ
Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidemia and lipid management in HIV-infected patients.
Lo J
Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):144-7. PubMed ID: 21297466
[TBL] [Abstract][Full Text] [Related]
7. Management of dyslipidemia in patients with human immunodeficiency virus.
Shalit P
Rev Cardiovasc Med; 2014; 15 Suppl 1():S38-46. PubMed ID: 24987862
[TBL] [Abstract][Full Text] [Related]
8. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
Ahmed MH; Al-Atta A; Hamad MA
Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
Maggi P; Di Biagio A; Rusconi S; Cicalini S; D'Abbraccio M; d'Ettorre G; Martinelli C; Nunnari G; Sighinolfi L; Spagnuolo V; Squillace N
BMC Infect Dis; 2017 Aug; 17(1):551. PubMed ID: 28793863
[TBL] [Abstract][Full Text] [Related]
10. Clinical management considerations for dyslipidemia in HIV-infected individuals.
Kirchner JT
Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection.
Kelesidis T; Currier JS
Endocrinol Metab Clin North Am; 2014 Sep; 43(3):665-84. PubMed ID: 25169560
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and pharmacologic management of the HIV-infected patient with dyslipidemia.
Hardwicke RL; Lewis ST; Grimes RM
J Assoc Nurses AIDS Care; 2010; 21(5):429-38. PubMed ID: 20303794
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular implications of HIV-induced dyslipidemia.
Giannarelli C; Klein RS; Badimon JJ
Atherosclerosis; 2011 Dec; 219(2):384-9. PubMed ID: 21722900
[TBL] [Abstract][Full Text] [Related]
14. HIV and its relationship to insulin resistance and lipid abnormalities.
Non LR; Escota GV; Powderly WG
Transl Res; 2017 May; 183():41-56. PubMed ID: 28068521
[TBL] [Abstract][Full Text] [Related]
15. Dyslipidemia in HIV patients.
Tungsiripat M; Aberg JA
Cleve Clin J Med; 2005 Dec; 72(12):1113-20. PubMed ID: 16392725
[TBL] [Abstract][Full Text] [Related]
16. Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection.
Troll JG
Curr Atheroscler Rep; 2011 Feb; 13(1):51-6. PubMed ID: 21181310
[TBL] [Abstract][Full Text] [Related]
17. Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management.
Nazari I; Feinstein MJ
Clin Microbiol Rev; 2024 Mar; 37(1):e0009822. PubMed ID: 38299802
[TBL] [Abstract][Full Text] [Related]
18. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.
Boccara F; Kumar PN; Caramelli B; Calmy A; López JAG; Bray S; Cyrille M; Rosenson RS;
J Am Coll Cardiol; 2020 May; 75(20):2570-2584. PubMed ID: 32234462
[TBL] [Abstract][Full Text] [Related]
19. Lipid metabolism in treated HIV Infection.
Dubé MP; Cadden JJ
Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):429-42. PubMed ID: 21663837
[TBL] [Abstract][Full Text] [Related]
20. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.
Zanetti HR; Roever L; Gonçalves A; Resende ES
Curr Atheroscler Rep; 2018 Feb; 20(2):9. PubMed ID: 29423787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
